Older AML patients not found to benefit from sequential GO and chemotherapy
10/24/2013
Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential combination of gemtuzumab ozogamicin (GO) and standard chemotherapy provides no benefit for older patients with acute myeloid leukemia (AML) and is too toxic for patients 70 years of age or more...
Study points to possible treatment for brain disorders
10/24/2013
Clemson University scientists are working to determine how neurons are generated, which is vital to providing treatment for neurological disorders like Tuberous Sclerosis Complex (TSC)...
Coffee consumption cuts liver cancer risk
10/23/2013
Good news for coffee drinkers: researchers from Italy have shown that coffee consumption reduces the risk of liver cancer by about 40%. And some of the results indicate that if you drink three cups a day, the risks are reduced by more than 50%...
Coffee consumption cuts liver cancer risk
10/23/2013
Good news for coffee drinkers: researchers from Italy have shown that coffee consumption reduces the risk of liver cancer by about 40%. And some of the results indicate that if you drink three cups a day, the risks are reduced by more than 50%...
Melanoma patients may benefit from new biomarker
10/23/2013
Researchers have discovered a biomarker that could help predict whether patients with melanoma harboring mutations in the BRAF gene are likely to respond to BRAF-targeted treatment. The discovery could help speed up treatment decisions, say the researchers...
Heavy air pollution in Canadian areas with excess cancers
10/23/2013
A study led by the University of California-Irvine found higher levels of air pollutants in a rural area near Canada's largest oil, gas and tar sand processing areas than in some of the most polluted cities in the world. Men living in this rural area also show higher rates of cancers known to be linked to the contaminants...
Melanoma patients may benefit from new biomarker
10/23/2013
Researchers have discovered a biomarker that could help predict whether patients with melanoma harboring mutations in the BRAF gene are likely to respond to BRAF-targeted treatment. The discovery could help speed up treatment decisions, say the researchers...
Heavy air pollution in Canadian areas with excess cancers
10/23/2013
A study led by the University of California-Irvine found higher levels of air pollutants in a rural area near Canada's largest oil, gas and tar sand processing areas than in some of the most polluted cities in the world. Men living in this rural area also show higher rates of cancers known to be linked to the contaminants...
BRCA-related breast and ovarian cancers showing early response to Investigational PARP inhibitor
10/23/2013
An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23...
The role played by estrogen in colon cancer prevention, treatment
10/23/2013
As the second leading cause of cancer-related deaths in the U.S., colon cancer affects both men and women and is expected to cause more than 50,000 deaths this year. University of Houston (UH) professor Cecilia Williams has been awarded a $1.56 million grant from the National Cancer Institute (NCI) to investigate the mechanistic basis for novel colon cancer prevention and therapy...